Form 8-K - Current report:
SEC Accession No. 0001193125-16-578661
Filing Date
2016-05-05
Accepted
2016-05-05 07:11:02
Documents
2
Period of Report
2016-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d193553d8k.htm 8-K 28116
2 EX-99.1 d193553dex991.htm EX-99.1 10012
  Complete submission text file 0001193125-16-578661.txt   39542
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 161621530
SIC: 2834 Pharmaceutical Preparations